CN Patent

CN110054615B — 三嗪类idh抑制剂甲磺酸盐的晶型

Assigned to Nanjing Sanhome Pharmaceutical Co Ltd · Expires 2021-06-15 · 5y expired

What this patent protects

本发明属于医药化学领域，涉及IDH抑制剂的甲磺酸盐的晶型及其制备方法，具体涉及式(I)的(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇的甲磺酸盐的晶型及其制备方法，所述的甲磺酸盐晶型可用于制备治疗癌症的药物，

USPTO Abstract

本发明属于医药化学领域，涉及IDH抑制剂的甲磺酸盐的晶型及其制备方法，具体涉及式(I)的(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇的甲磺酸盐的晶型及其制备方法，所述的甲磺酸盐晶型可用于制备治疗癌症的药物，

Drugs covered by this patent

Patent Metadata

Patent number
CN110054615B
Jurisdiction
CN
Classification
—
Expires
2021-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.